Kalaris Therapeutics KLRS
NASDAQ KLRS
$2.70 -0.15 (-5.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kalaris Therapeutics (KLRS) Other Non Operating Income (2019 - 2026)

Updated

Kalaris Therapeutics (KLRS) posted Other Non Operating Income of $871,000 for Q2 2026, down 3.9% from $906,000 a year earlier and down 10.8% from the prior quarter.

Analysis

Kalaris Therapeutics (KLRS) Other Non Operating Income (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Other Non Operating Income at Kalaris Therapeutics was $3.5 million, down 10.5% year-over-year; for FY2025, it came in at $2.75 million, up 31.9% from FY2024.

  • Annual Other Non Operating Income shows a five-year compound annual growth rate of 69.8% (FY2020 to FY2025).
  • In prior years, Kalaris Therapeutics' Other Non Operating Income was $2.08 million in FY2024 (-42.5%), $3.62 million in FY2023 (+932.2%), $351,000 in FY2022 and -$2.45 million in FY2021.
  • Quarterly Other Non Operating Income has run from a low of -$1.22 million in Q4 2021 to a high of $1.23 million in Q1 2025 over five years.
  • On a year-over-year basis, Other Non Operating Income has declined in each of the last three quarters, with growth averaging 19.3% over the last seven quarters.
  • The strongest year-over-year quarter for Other Non Operating Income in the past five years was Q3 2023, with growth of 455.7%; the weakest was Q1 2024, with a decline of 96.3%.
  • According to Business Quant data, Other Non Operating Income for the three prior quarters was $977,000 (Q1 2026), $803,000 (Q4 2025) and $847,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Kalaris Therapeutics 64.27 Mn 64.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 871,000.00
Mar 31, 2026 977,000.00
Dec 31, 2025 803,000.00
Sep 30, 2025 847,000.00
Jun 30, 2025 906,000.00
Mar 31, 2025 1.23 Mn
Dec 31, 2024 1.22 Mn
Sep 30, 2024 549,000.00
Jun 30, 2024 311,000.00
Mar 31, 2024 27,000.00
Dec 31, 2023 1.21 Mn
Sep 30, 2023 1.17 Mn
Jun 30, 2023 521,000.00
Mar 31, 2023 723,000.00
Dec 31, 2022 985,000.00
Sep 30, 2022 210,000.00
Jun 30, 2022 -27,000.00
Mar 31, 2022 -818,000.00
Dec 31, 2021 -1.22 Mn
Sep 30, 2021 -259,000.00
API Access

Kalaris Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=KLRS&period=max&api_key=YOUR_API_KEY